tradingkey.logo

Acurx Pharmaceuticals Inc <ACXP.OQ> expected to post a loss of 15 cents a share - Earnings Preview

ReutersMay 9, 2025 3:24 PM
  • Acurx Pharmaceuticals Inc ACXP.OQ ACXP.O is expected to show no change in quarterly revenue when it reports results on May 13 for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Acurx Pharmaceuticals Inc is for a loss of 15 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Acurx Pharmaceuticals Inc is $5.00​, above​ its last closing price of $0.38. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.18

-0.16

Beat

11.1

Sep. 30 2024

-0.23

-0.20

-0.17

Beat

15

Jun. 30 2024

-0.22

-0.22

-0.26

Missed

-18.2​

Mar. 31 2024

-0.24

-0.24

-0.28

Missed

-16.7

​​Dec. 31 2023

-0.26

-0.37

Missed

-42.3

Sep. 30 2023

-0.28

-0.27

-0.24

Beat

11.1​

Jun. 30 2023

-0.27

-0.27

-0.28

Missed

-3.7

Mar. 31 2023

-0.30

-0.29

-0.25

Beat

15.3

This summary was machine generated May 9 at 15:24 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI